搜索临床试验以:Boceprevir、聚乙二醇干扰素 alfa 2b 和利巴韦林
总计1263个结果
-
Janssen Pharmaceutical K.K.完全的
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (Co-Sponsor for USA)完全的
-
University Hospital, Geneva完全的
-
Dermatologic Cooperative Oncology Group未知治疗 | 佐剂 | III期恶性黑色素瘤 | Interferon Alpha德国
-
Vertex Pharmaceuticals IncorporatedTibotec, Inc完全的
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
French National Agency for Research on AIDS and...Hoffmann-La Roche完全的
-
Foundation for Liver Research完全的
-
M.D. Anderson Cancer CenterEisai Inc.终止
-
Bristol-Myers Squibb完全的丙型肝炎法国, 英国, 西班牙, 美国, 意大利, 波多黎各, 希腊
-
National Institute of Allergy and Infectious Diseases...完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)招聘中
-
Third Affiliated Hospital, Sun Yat-Sen UniversityPeking University; Huazhong University of Science and Technology; First People's Hospital of Foshan 和其他合作者未知
-
Services Institute of Medical Sciences, PakistanGetz Pharma完全的
-
Pacific Health FoundationHoffmann-La Roche完全的
-
Pusan National University Yangsan HospitalPusan National University Hospital; Inje University; Severance Hospital; Soon Chun Hyang University 和其他合作者未知
-
ANRS, Emerging Infectious DiseasesBristol-Myers Squibb完全的
-
Hoffmann-La Roche完全的肾细胞癌 | 慢性粒细胞白血病 | 恶性黑色素瘤加拿大, 印度, 保加利亚, 俄罗斯联邦, 西班牙, 南非, 斯洛伐克
-
Novartis PharmaceuticalsHuman Genome Sciences Inc.终止
-
Xiamen Amoytop Biotech Co., Ltd.Peking University People's Hospital完全的
-
Mitsubishi Tanabe Pharma Corporation完全的
-
Merck Sharp & Dohme LLC完全的
-
José Antonio CarrionInstituto de Salud Carlos III完全的慢性乙型肝炎(HBeAg 阴性)
-
Xiamen Amoytop Biotech Co., Ltd.Peking University First Hospital完全的
-
Chinese University of Hong KongHoffmann-La Roche完全的
-
Intarcia Therapeutics完全的
-
Third Affiliated Hospital, Sun Yat-Sen UniversityPeking University; Huazhong University of Science and Technology; First People's Hospital of Foshan 和其他合作者未知
-
Seng Gee LimMerck Sharp & Dohme LLC; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital 和其他合作者完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)终止